In this study, we conducted radiogenomic analysis, and the observed results demonstrate that COMB-Radscore is associated with the abundance and functional status of CD8 + T cells, which potentially elucidates the underlying mechanism for the accurate prediction of immunotherapy efficacy in NSCLC patients by COMB-Radscore. This evidence concerns the gene CD8A and non-small cell lung carcinoma.